Search Results - "Çaglayan, Çaglar"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2

    A population‐based multistate model for diffuse large B‐cell lymphoma–specific mortality in older patients by Çağlayan, Çağlar, Goldstein, Jordan S., Ayer, Turgay, Rai, Ashish, Flowers, Christopher R.

    Published in Cancer (01-06-2019)
    “…Background Despite effective therapies, outcomes for diffuse large B‐cell lymphoma (DLCBL) remain heterogeneous in older individuals due to comorbid diseases…”
    Get full text
    Journal Article
  3. 3

    Enhancing the Management of Deployment-Limiting Medical Conditions in the U.S. Department of Navy Leveraging Electronic Health Records and Predictive Analytics Methods by Çağlayan, Çağlar, Panaggio, Mark J, Ramachandran, Raghav, Wang, Winnie, McShea, Michael, Boggs-Wilkerson, Denise, de Geus, John, Mercado, Michael

    Published in Military medicine (19-08-2024)
    “…Deployment-limiting medical conditions (DLMCs) such as debilitating injuries and conditions may interfere with the ability of military service members (SMs) to…”
    Get full text
    Journal Article
  4. 4

    A Data-Driven Framework for Identifying Intensive Care Unit Admissions Colonized With Multidrug-Resistant Organisms by Çaǧlayan, Çaǧlar, Barnes, Sean L, Pineles, Lisa L, Harris, Anthony D, Klein, Eili Y

    Published in Frontiers in public health (17-03-2022)
    “…The rising prevalence of multi-drug resistant organisms (MDROs), such as Methicillin-resistant (MRSA), Vancomycin-resistant (VRE), and Carbapenem-resistant…”
    Get full text
    Journal Article
  5. 5

    Prognostic value of sst2 in long-term mortality in acute heart failure by Matyar, Selcuk, Açıkalın Akpınar, Ayça, Dişel, Nezihat Rana, Avci, Akkan, Çağlayan, Çağlar Emre, Yıldırım, Abdullah, Akpınar, Onur

    Published in Acta Cardiologica (24-09-2024)
    “…The use of biochemical markers in ADHF is considered valuable both in the diagnosis and treatment of diseases and in follow-up. This study aimed to investigate…”
    Get full text
    Journal Article
  6. 6

    Assessing the Effectiveness of Treatment Sequences for Older Patients With High-risk Follicular Lymphoma With a Multistate Model by Çağlayan, Çağlar, Terawaki, Hiromi, Ayer, Turgay, Goldstein, Jordan S., Rai, Ashish, Chen, Qiushi, Flowers, Christopher

    Published in Clinical lymphoma, myeloma and leukemia (01-05-2019)
    “…Disease progression within < 2 years of initial chemoimmunotherapy and patient age > 60 years have been associated with poor overall survival (OS) in…”
    Get full text
    Journal Article
  7. 7

    Microsimulation Modeling in Oncology by Çağlayan, Çağlar, Terawaki, Hiromi, Chen, Qiushi, Rai, Ashish, Ayer, Turgay, Flowers, Christopher R

    Published in JCO clinical cancer informatics (01-12-2018)
    “…Microsimulation is a modeling technique that uses a sample size of individual units (microunits), each with a unique set of attributes, and allows for the…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Riociguat Use in a Patient with Sickle Cell Anemia Related Chronic Thromboembolic Pulmonary Hypertension by Baydar, Oya, Hanta, Ismail, Othman, Orhan, Caglayan, Caglar Emre

    Published in Turkish Thoracic Journal (09-09-2019)
    “…Introduction: Chronic thromboembolic pulmonary hypertension is a devastating complication of sickle cell anemia and it has limited treatment options. Riociguat…”
    Get full text
    Journal Article
  10. 10

    Is Nebivolol Really Effective in Preventing Contrast Induced Nephropathy? by Altunoren, Orcun, Balli, Mehmet, Eren, Necmi, Tasolar, Hakan, Arpaci, Abdullah, Caglayan, Caglar Emre, Yavuz, Yasemin Coskun, Gungor, Ozkan

    Published in Kidney & blood pressure research (01-01-2015)
    “…Background/Aims: Contrast induced nephropathy (CIN) has multifactorial etiopatogenesis including oxidative stress and vasoconstriction. Nebivolol is an…”
    Get full text
    Journal Article
  11. 11
  12. 12

    A Multi-State Model for Senior Patients with Diffuse Large B Cell Lymphoma by Caglayan, Caglar, Goldstein, Jordan S., Rai, Ashish, Flowers, Christopher

    Published in Blood (08-12-2017)
    “…Introduction: Diffuse large B-cell lymphoma (DLCBL) is the most common lymphoid malignancy in the United States. The combination of rituximab,…”
    Get full text
    Journal Article
  13. 13

    Abstract 15653: Optimizing the Screening Algorithm for Critical Congenital Heart Disease: A Data-Driven Approach by Oster, Matthew, Caglayan, Caglar, Simeone, Regina, Keskinocak, Pinar, Ayer, Turgay

    Published in Circulation (New York, N.Y.) (10-11-2015)
    “…IntroductionScreening for critical congenital heart disease (CCHD) using pulse oximetry is performed with various algorithms in the United States, with none of…”
    Get full text
    Journal Article
  14. 14

    A Multi-State Model for Follicular Lymphoma in Patients with Early Progression to Second Line Therapy by Caglayan, Caglar, Terawaki, Hiromi, Ayer, Turgay, Goldstein, Jordan S., Rai, Ashish, Chen, Qiushi, Flowers, Christopher

    Published in Blood (08-12-2017)
    “…Introduction: Follicular Lymphoma (FL) is the second most frequent lymphoma subtype, with a rapidly increasing incidence rate. Progression of disease within…”
    Get full text
    Journal Article
  15. 15

    Predicting Vancomycin-Resistant Enterococci (VRE) and Carbapenem-Resistant Organism (CRO) Colonization in the Intensive Care Unit by Çaǧlayan, Çaǧlar, Levin, Scott, Milstone, Aaron Michael, Tamma, Pranita, Simner, Patricia, Goodman, Katherine, Amoah, Joe, Smith, Aria, Toerper, Matt, Barnes, Sean, Klein, Eili

    “…Background: Rapidly identifying patients colonized with multidrug-resistant organisms (MDROs) upon ICU admission is critical to control and prevent the spread…”
    Get full text
    Journal Article
  16. 16

    A multistate model for follicular lymphoma (FL) patients (pts) who experience early progression by Terawaki, Hiromi, Caglayan, Caglar, Chen, Qiushi, Rai, Ashish, Ayer, Turgay, Flowers, Christopher

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only e18164 Background: FL is the second most frequent lymphoma subtype. Approximately 20% of FL pts experience disease progression within two years…”
    Get full text
    Journal Article
  17. 17

    Team Based, Risk Adjusted Staffing During a Pandemic: An Agent Based Approach by Prabhu, Vishnunarayan Girishan, Taaffe, Kevin, Caglayan, Caglar, Isik, Tugce, Song, Yongjia, Hand, William

    Published in 2020 Winter Simulation Conference (WSC) (14-12-2020)
    “…Since the World Health Organization declared the novel coronavirus disease a pandemic, more than 2 million cases of infections and 140,000 deaths have been…”
    Get full text
    Conference Proceeding
  18. 18
  19. 19